AlloVir, Inc.
ALVR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $183 | $183 | $49 | $48 |
| - Cash | $42 | $88 | $101 | $118 |
| + Debt | $2 | $0 | $0 | $0 |
| Enterprise Value | $143 | $95 | -$52 | -$70 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$12 | -$12 | -$10 | -$19 |
| % Margin | – | – | – | – |
| Net Income | -$12 | -$11 | $0 | -$18 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.64 | -0.61 | 0 | -3.68 |
| % Growth | -4.9% | – | 100% | – |
| Operating Cash Flow | -$11 | -$13 | -$7 | -$4 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$12 | -$13 | -$7 | -$4 |